Trane Technologies plc (TT) stock analysis
Close on Nov 11, 2026Market cap $93.00BP/E 30.0Yield 0.89%
StockData Score
Prices as of Nov 11, 2026How the score works
Strong23 of 30 checks passed
Trane Technologies passes 23 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 4/6
- Past performance
- 6/6
- Financial health
- 5/6
- Dividend
- 4/6
What stands out
Trading below fair value
The share price of $424.84 is below our fair value estimate of $473.33.
Return on equity over 15%
Return on equity was 36.1% over the last twelve months and averaged 30.8% over five years.
Return on capital over 10%
Return on invested capital was 25.0%, above the 10% that usually covers the cost of capital.
Earnings grew over 5 years
Net income grew 27.8% a year on average over the last five fiscal years.
What to watch
Margin of safety under 20%
The price is 10.2% below fair value, less than the 20% cushion we look for.
High debt
Debt is 46.3% of shareholders' equity, above the 40% we consider low.
Earnings growth not accelerating
Net income grew 7.5% over the last twelve months, against a 5-year average of 27.8% a year.
P/B above the industry
Trane Technologies's price-to-book of 10.21 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Valuation4/6
P/E below its 5-year median
Trane Technologies's P/E of 30.0 is below its own 5-year median of 32.0.
P/E below the industry
Trane Technologies's P/E of 30.0 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.
EV/EBITDA below its 5-year median
Trane Technologies's EV/EBITDA of 21.3 is below its 5-year median of 22.2.
P/B above the industry
Trane Technologies's price-to-book of 10.21 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Trading below fair value
The share price of $424.84 is below our fair value estimate of $473.33.
Margin of safety under 20%
The price is 10.2% below fair value, less than the 20% cushion we look for.
Growth4/6
Revenue growing 10%+ a year
Revenue grew 10.1% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 20.2% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew 7.5% over the last twelve months, against a 5-year average of 27.8% a year.
Growing faster than the industry
Revenue grew 10.3% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.
Guidance raised
Trane Technologies raised its full-year 2026 organic revenue growth outlook on Jul 30, 2026.
Gross margin trend
This company does not report gross profit.
Past performance6/6
Return on equity over 15%
Return on equity was 36.1% over the last twelve months and averaged 30.8% over five years.
Return on capital over 10%
Return on invested capital was 25.0%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Trane Technologies's return on equity of 36.1% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.
Earnings grew over 5 years
Net income grew 27.8% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 13.6% over the last twelve months, against a 5-year average of 11.8%.
Net margin above the industry
Trane Technologies's net margin of 13.6% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.
Financial health5/6
High debt
Debt is 46.3% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 82.3% five years ago to 46.3%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 99.3% of total debt.
Interest well covered
Operating income covers interest expense 19.2 times.
Short-term assets cover short-term debts
Current assets are 1.12 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 6.02; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
Trane Technologies paid dividends worth 0.7% of the share price over the last twelve months.
Yield below Treasuries
The 0.7% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Trane Technologies yields 0.7%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 28.6% of net income.
Covered by free cash flow
Dividends take 23.6% of free cash flow.
Fair value
How we estimate itOur estimate per share
$473.33
The share price is 10% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 34.2× | 32.0× | 36.5× | $484.60 | 53% |
| EV/EBITDA | 23.0× | 22.2× | 23.7× | $460.46 | 47% |
| Earnings powerleft out, too far from the others | 10.6% cost of equity | – | – | $110.87 | – |
| Fair value | $473.33 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 32.0
- Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $692.58M
- Value traded per 1% price move
- $424.11M
Downside
Low risk
- Typical loss in a bad month
- 12.8%
- Volatility (annualized)
- 30%
- Sharpe ratio, 1 year
- -0.21
- Beta to the S&P 500 (5Y)
- 1.13
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +7.5% | +10.1% | +11.4% | +4.8% | |
| Operating income | +13.4% | +17.9% | +20.9% | +10.3% | |
| Net income | +13.7% | +18.4% | +27.8% | +15.9% | |
| EPS, diluted | +15.5% | +20.2% | +29.8% | +18.0% | |
| Free cash flow | +1.3% | +32.4% | +16.9% | +16.0% | |
| Dividend per share | +11.9% | +11.9% | +12.1% | +12.5% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 23.7% | 12.5% | 36.4% | |
| Return on assets | 8.7% | 4.4% | 14.0% | |
| Current ratio | 1.55 | 1.59 | 1.25 | |
| Debt to equity | 0.61 | 0.82 | 0.54 | |
| Net debt to EBITDA | 1.20× | 1.08× | 0.66× | |
| Interest coverage | 7.2× | 6.2× | 17.5× | |
| Inventory turnover | 6.7× | 7.0× | – | |
| Capex to revenue | 1.4% | 1.2% | 1.8% | |
| Diluted shares | 262M | 243M | 225M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Trane Technologies generated $11.82B from operations and spent $10.76B on capital expenditure, dividends and share buybacks. 15% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 13.7% | 1.03× | 2.59× | 36.4% |
| FY2024 | 12.9% | 1.00× | 2.74× | 35.5% |
| FY2023 | 11.4% | 0.94× | 2.86× | 30.9% |
| FY2022 | 11.0% | 0.88× | 2.93× | 28.5% |
| FY2021 | 10.1% | 0.78× | 2.86× | 22.5% |
| FY2020 | 6.9% | 0.64× | 2.83× | 12.5% |
| FY2019 | 10.8% | 0.68× | 2.69× | 19.7% |
| FY2018 | 10.8% | 0.68× | 2.55× | 18.9% |
| FY2017 | 9.2% | 0.80× | 2.58× | 18.9% |
| FY2016 | 10.9% | 0.79× | 2.74× | 23.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$2.92B
- Cash generatingOperating cash flow above zero$3.19B
- Return on assets improvedROA up on the prior year13.2% → 14.5%
- Earnings backed by cashOperating cash flow above net income$3.19B vs $2.92B
- Less leverageLong-term debt to assets fell21.4% → 18.3%
- Better liquidityCurrent ratio rose1.21 → 1.25
- No dilutionShare count did not rise228M → 225M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose1.02 → 1.06
See a number that looks wrong?